Therapeutic approaches to lung aging

Peter J. Barnes (London, United Kingdom)

Source: International Congress 2016 – The future is now: the challenge of ageing in respiratory medicine
Session: The future is now: the challenge of ageing in respiratory medicine
Session type: Hot topics
Number: 3496

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Peter J. Barnes (London, United Kingdom). Therapeutic approaches to lung aging. International Congress 2016 – The future is now: the challenge of ageing in respiratory medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular effects of innovative therapies in lung cancer
Source: Eur Respir Monogr 2020; 88: 154-166
Year: 2020


Common therapeutic approaches in IPF and lung cancer
Source: Research Seminar 2015
Year: 2015


Will we really achieve anti-ageing lung treatments? Abnormal lung ageing in COPD
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


Pharmacological and Non-pharmacological therapies that modulare lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021



Lung disease induced by newer therapies for lung cancer: an update
Source: Annual Congress 2006 - Drug-induced lung injury – new aspects
Year: 2006


Innovative local therapies in lung cancer
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


Innovative systemic lung cancer therapies
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


PG11 Modern approaches in lung cancer diagnostics and therapy
Source: Paris 2018 - Educational material
Year: 2018

Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019


New and anticipated therapeutic developments in management of non-small-cell lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015

Exploiting metabolomic approaches to aid in the diagnosis of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

Metabolic modification as a potential therapeutics approach in lung cancer
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013


Hallmarks of the ageing lung
Source: Eur Respir J 2015; 45: 807-827
Year: 2015



Biomarkers in early-detection of lung cancer: current concepts
Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts
Year: 2021

Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016


Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015